PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy

Bian, X ; Gao, J ; Luo, F ; Rui, C ; Zheng, T ; Wang, D ; Wang, Y ; Roberts, T M ; Liu, P ; Zhao, J J ; Cheng, H

Oncogene, 2018-01, Vol.37 (3), p.341-351 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível